ClinicalTrials.gov record
Recruiting Phase 1 Interventional

Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain

ClinicalTrials.gov ID: NCT07197645

Public ClinicalTrials.gov record NCT07197645. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 12:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1 Pharmacokinetic, Dosimetry, Safety, and Dose Optimization Study for a Single Dose of TLX090-Tx (153SmDOTMP) to Treat Metastatic Bone Pain

Study identification

NCT ID
NCT07197645
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1
Lead sponsor
Telix Pharmaceuticals (Innovations) Pty Limited
Industry
Enrollment
33 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 20, 2025
Primary completion
Apr 25, 2027
Completion
Jul 4, 2027
Last update posted
May 13, 2026

2025 – 2027

United States locations

U.S. sites
6
U.S. states
2
U.S. cities
2
Facility City State ZIP Site status
Biogenix Molecular, LLC, CIRA Health Miami Florida 33165 Recruiting
NovaCure Miami Florida 33176 Recruiting
Houston Metro Urology Houston Texas 77027 Recruiting
Oncology Consultants Houston Texas 77030 Recruiting
Excel Diagnostics and Nuclear Oncology Center Houston Texas 77042 Recruiting
University of Texas Medical Branch at Galveston (UTMB) Houston Texas 77555 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07197645, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 13, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07197645 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →